The circadian clock, which regulates cellular physiology, such as energy metabolism, resides in each cell level throughout the body. Recently, it has been elucidated that the cellular circadian clock is closely linked with cellular differentiation. 
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start generating a circadian rhythm in a cell-autonomous manner after differentiation induction in vitro (Kowalska, Moriggi, Bauer, Dibner, & Brown, 2010; Yagita et al., 2010) . In addition, we have found that the circadian clock oscillation disappears again after differentiated cells are reprogrammed, and have thus revealed that the circadian clock and cell differentiation are closely coupled (Yagita et al., 2010) . Furthermore, recent studies have shown that the misregulation of cellular differentiation by the genetic ablation of DNA methyltransferases (Dnmt1, 3a, 3b) resulted in a defect of differentiation-coupled emergence of circadian clock oscillation . This result suggests that the intact circadian clock in mammalian cells is likely to require an adequate cellular differentiation process. Furthermore, it was recently reported that CLOCK protein is suppressed post-transcriptionally in nonrhythmic cells, such as undifferentiated ESCs and dysdifferentiated ESCs, as well as precircadian clock developed mouse embryonic hearts (Umemura et al., 2017) , which is one of the key mechanisms that suppress circadian clock oscillation in those cells.
Meanwhile, it has been reported that abnormalities in the cell differentiation process, that is, abnormalities in a wide range of changes in cell lineage-specific gene expression profiles controlled by epigenetic regulations, may be related to carcinogenesis (Bonasio, Tu, & Reinberg, 2010; Feinberg, 2007; Gaudet et al., 2003; Hikichi et al., 2013; Lee & Young, 2013) . Recent developments in whole-genome analysis technology have led to reports of pediatric cancer with an extremely low rate of gene mutation (Lee et al., 2012; Mack et al., 2014; Pugh et al., 2012; Zhang et al., 2012) , and there is an emerging idea regarding epigenetic change as a class of oncogenic factors (Brien, Valerio, & Armstrong, 2016; Feinberg, Koldobskiy, & Göndör, 2016; Suvà, Riggi, & Bernstein, 2013) . Epigenetic carcinogenesis due to altered cell differentiation control has recently been reported in an in vivo reprogramming mouse model using four reprogramming factors, namely Oct3/4 (also known as Pou5f1), Sox2, Klf4, and c-Myc (Ohnishi et al., 2014) . Tumors formed in mouse kidneys by premature in vivo reprogramming resembled Wilms tumors, a human embryonic kidney tumor, indicating the possibility that certain types of cancer are formed via a dedifferentiation-mediated carcinogenic process (Ohnishi et al., 2014) .
In this study, the relationships between the circadian clock and misregulation of normal cellular differentiation in vivo were examined using the mouse in vivo reprogramming model. Here, we report that circadian rhythms were impaired in mouse kidney tumors which formed due to an abnormal differentiation state induced by partial in vivo reprogramming. Furthermore, the expression of CLOCK protein was suppressed post-transcriptionally in the tumor tissues. These results were consistent with our previous reports (Umemura et al., 2017) .
Moreover, the lack of CLOCK was also observed in human Wilms tumor tissues, suggesting that the circadian clock was disrupted. In addition, the similar finding was also obtained from malignant rhabdoid tumor (MRT), a type of pediatric renal tumor shown to be formed via epigenomic carcinogenesis by inactivation of SNF5 (SMARCB1) (MasliahPlanchon, Bièche, Guinebretière, Bourdeaut, & Delattre, 2015; Versteege, Sévenet, Lange, & Rousseau-Merck, 1998) . The absence of CLOCK might reflect not only a possible mechanism that disrupts circadian clock oscillation, but also the carcinogenic process through abnormal differentiation. They may have added new pathophysiological significance to the circadian rhythm.
| RESULTS

| Bioluminescence imaging of partial in vivo reprogrammed somatic cells
To measure circadian rhythm from reprogrammed somatic cells, first, we established Tet-OSKM/mPer2-luc ESCs by introducing mouse Per2 promoter-driven luciferase (mPer2-luc) as a circadian rhythm reporter into the Tet-OSKM ESCs with doxycycline (Dox)-inducible four reprogramming factors (Oct3/4, Sox2, Klf4, and c-Myc). Discernable circadian oscillation of mPer2-luc bioluminescence was not observed within in vitro 7-day differentiation of the ESCs, but was observed after 21 days (Figure 1a ). When the dedifferentiation of 21-day differentiated cells was induced by Dox treatment, we observed ESC-like colonies and expression of the undifferentiated cell marker NANOG (Figure 1b,c) , confirming the successful reprogramming of these cells. Moreover, the circadian bioluminescence rhythm disappeared in the reprogrammed induced pluripotent stem (iPS) cells (Figure 1d ). These results were consistent with previous findings (Yagita et al., 2010) . Then, using the Tet-OSKM/mPer2-luc ESCs, we generated chimeric mice. The mice at over 4 weeks of age were given 0.2 or 2 mg/ml Dox in their drinking water with 10 mg/ml sucrose to develop tumors. When the mice became morbid within 10-20 days, Dox was withdrawn for several days and the mice were killed, and then, circadian oscillation was analyzed using a bioluminescence imaging system as shown in the schema of experimental procedure (Figure 1e ).
| Circadian rhythm disruption in mouse kidney tumors induced by partial in vivo reprogramming
In control kidneys, which the chimeric mice had not been treated with Dox, no obvious abnormalities were observed | Genes to Cells OHASHI et Al. macroscopically or microscopically, and normal proximal and distal renal tubules and glomeruli were formed in the kidney (Figure 2a-c) . Real-time bioluminescence analysis using a macroscopic imaging analyzer showed many luminescent spots in the ex vivo cultured kidney slice, confirming differentiation of the Tet-OSKM/mPer2-luc ESCs into normal kidney tissues (Figure 2d ). Because in vivo reprogramming-induced mouse kidney tumors are developed almost exclusively in the cortex, we measured luminescence rhythms with a particular focus on the cortex and observed apparent bioluminescence rhythms over the whole cortex (Fig. 2d,e) . We also measured rhythms in 30 regions of interest (ROIs) and confirmed clear circadian rhythms in each ROI (Figure 2d,f) . These results confirmed again that circadian rhythms were emerged from the normal kidney cells developed from the ESCs. However, when the mice had undergone temporal reprogramming by Dox treatment, the kidneys were markedly enlarged and developed Wilms tumor-like tumors consisting of undifferentiated cells (Figure 2g-i) , consistent with the previous report (Ohnishi et al., 2014) . In addition, these tumors had pronounced luminescence, indicating that the developed tumors were the ES-derived cells (Figure 2j ). When luminescence rhythms in these tumors were measured, no clear circadian rhythms were observed in the whole tumor (Figure 2j,k) . Furthermore, all luminescence traces in 30 ROIs indicated no clear circadian rhythms (Figure 2j, l) , suggesting that the absence of observable circadian oscillation was caused by the impaired circadian clock in the tumor cells, rather than desynchronization of individual cells. Similar results were also observed in the kidney tumors from other three mice treated with Dox ( Figure S1 ). Quantitative comparisons by FFT analysis confirmed that circadian rhythms were significantly impaired in all mouse kidney tumors compared with control kidneys (Figure 2m ). 
| Mechanisms of circadian clock disruption in mouse kidney tumor induced by partial in vivo reprogramming
To determine the underlying mechanism of circadian rhythm impairment in in vivo reprogramming-induced mouse renal tumor cells, we examined CLOCK expression in the kidney tumors, as our previous report suggests (Umemura et al., 2017) . We found that CLOCK was suppressed in the tumor cells, whereas it was expressed in the nucleus of control renal cells (Figure 3a ). Because our RNA sequence (RNA-seq) analysis in this study showed the Clock mRNA was expressed in kidney tumors (Figure 3b , Table S1 ), these results suggest that CLOCK protein expression was suppressed post-transcriptionally, as shown in precircadian clock developed mouse embryos and ESCs (Umemura et al., 2017) . In addition, our RNA-seq analysis showed Npas2, which is a paralog of Clock and complements the CLOCK protein function in neurons and some other tissues (DeBruyne, Weaver, & Reppert, 2007a,b) , was hardly expressed in the control kidney and the tumor cells (Figure 3b) . The results indicate that suppression of the CLOCK protein is a critical factor for the impairment of the circadian rhythm in partial in vivo reprogramminginduced renal tumors in mice. 
| Circadian clockwork disruption in human Wilms tumors
Because in vivo reprogramming-induced mouse kidney tumors have been shown to resemble human Wilms tumor in terms of not only morphology but also gene expression profiles (Ohnishi et al., 2014) , we investigated whether the mechanisms inhibiting the circadian clock oscillation are observed in human Wilms tumor tissues. An immunohistochemical analysis did not detect the CLOCK protein in two independent Wilms tumor samples, whereas CLOCK was expressed in the nucleus of intact renal tissues (Figure 4a ,b, Figure S2a ,b). Expression of CLOCK mRNA in tumor tissues was previously reported in comprehensive gene expression analyses of Wilms tumor tissues (Yusenko et al., 2009) , which suggests that the CLOCK protein expression is also repressed post-transcriptionally in human Wilms tumors cells. These results suggest that the circadian molecular clockwork is disrupted in Wilms tumor tissues and support that the partial in vivo reprogramming-induced mouse kidney tumor is a model of human Wilms tumors (Ohnishi et al., 2014) . Furthermore, we also examined the expression of CLOCK in MRT ( Figure S3a ). This is a type of childhood kidney tumor in which an epigenomic carcinogenesis mechanism via the inactivation of SNF5 (SMARCB1), which encodes SWI/SNF ATP-dependent chromatin-remodeling factor, was found to be involved (Masliah-Planchon et al., 2015; Versteege et al., 1998) . Similar to Wilms tumors, immunohistochemical studies showed the lack of CLOCK protein in the MRT tissue ( Figure S3b) . These results suggest that the mechanisms that disrupt circadian clock linked with cellular differentiation states may exist not only in human Wilms tumors but also in various types of cancer involving dedifferentiation or abnormal differentiation.
| DISCUSSION
The circadian clock regulates expression of many other genes through the regulation of a feedback loop with the clock genes at the core and is thereby controlling various cellular physiological functions (Bass & Lazar, 2016) .
In the present study, we showed the disruption of circadian rhythm in mouse kidney tumors developed by abnormal cell differentiation and found a lack of CLOCK protein in the developed mouse tumors. Furthermore, we showed a similar lack of CLOCK expressions in human Wilms tumor and MRT. These results suggest that the mechanisms inhibiting circadian clock oscillation were common. In addition, the disruption of the circadian clock may be a phenotype not caused by core clock gene mutations, but rather caused by abnormal cell differentiation. If correct, the circadian clock disruption may reflect the underlying etiology of cellular differentiation control in some cases.
In the tumorigenic process of Wilms tumors, nephrogenic rests are widely considered to be its origin (Popov, Sebire, & Vujanic, 2016) . However, Ohnishi et al. (2014) have suggested the involvement of cell-fate conversion through the dedifferentiation process. Our results showed the lack of CLOCK in both Wilms tumors and partial in vivo reprogrammed mouse renal tumors. Furthermore, the common point was also observed in MRT, which is considered to be an epigenetic cancer. These results do not necessarily deny the idea that Wilms tumors are caused by abnormal proliferation of residual immature cells, but support the possibility of carcinogenesis and malignant transformation because of a dedifferentiation-mediated abnormal cellular differentiation state.
With recent advances in molecular biological research, cancer cell-specific molecular pathology in functions such as proliferation, invasion, and metastasis is increasingly being showed. Consequently, development of biomarkers for various types of cancers has advanced. Many molecularly targeted drugs have been developed, which unlike conventional cytotoxic anticancer agents, such as platinum-based agents, act on the expression of genes and proteins selected as therapeutic targets (de Bono & Ashworth, 2010; Falco et al., 2016) . Their effects have been showed in a number of clinical trials, and a paradigm shift is occurring from previous organ-oriented cancer treatments to treatments based on the cancer's molecular pathophysiology (Schwaederle et al., 2015; Wheler et al., 2016) . However, the effectiveness of personalized medicine is still limited, and patient selection systems are required to maximize the benefits and address medical economic problems (Gonzalez de Castro, Clarke, Al-Lazikani, & Workman, 2013; Heinemann, Douillard, Ducreux, & Peeters, 2013; Le Tourneau et al., 2015) . Under these circumstances, we suggested the possibility of evaluating cancer based on molecular pathology from a new perspective, that of the closely coupled relationship between cell differentiation and the circadian clock. Further analyses using clinical specimens should be carried out in the future to clarify the significance.
In summary, our present study has showed the possibility that disruption of the molecular mechanism for circadian clock oscillation in tumors not only causes rhythm disorders, but also reflects the underlying etiology of cellular differentiation abnormalities of tumor cells. We believe that there is pathological significance in the relationship between the molecular basis of the circadian clock and the molecular pathophysiology of cancers. New understanding and evaluation of cancer cells from the viewpoint of the circadian clock may help future treatment strategies, in line with personalized therapy using molecularly targeted drugs.
| EXPERIMENTAL PROCEDURES
| Data availability
The datasets generated during and/or analyzed during the current study are available from the corresponding authors on reasonable request.
| Ethics statement
All procedures with animals were approved by the Kyoto Prefectural University of Medicine Animal Care Committee. This study using human tumor samples was approved by the Ethics Committee of Kyoto Prefectural University of Medicine (approved number: ERB-E-72). According to the Declaration of Helsinki, prior written informed consent was obtained from all the parents/legal representatives. All experiments were carried out in accordance with the institutional guidelines and regulations.
| Cell culture
Rosa26-M2rtTA TetO-OSKM ESC line was provided by Dr Yasuhiro Yamada (Kyoto University, Japan), whose laboratory established the cell line as described in previous report (Ohnishi et al., 2014) . The Rosa26-M2rtTA TetO-OSKM ESC line stably expressing the mouse Per2 promoter-driven luciferase reporters was established as previously described (Umemura et al., 2017) . Briefly, 3 μg of mPer2:luc-pT2A plasmid with a Zeocin ™ selection marker and 1 μg of a Tol2 transposase expression vector (pCAGGS-TP) were diluted in 40 μl of culture medium and 12 μl of FuGENE 6 (Promega) and mixed well. After a 15-min incubation period at room temperature, the mixture was added to 2-2.5×10 5 cells. The cells were selected using 10 μg/ml Zeocin ™ (Invitrogen).
| Chimeric mice
Chimeric embryos were generated from Rosa26-M2rtTA TetO-OSKM mPer2-luc ESCs by injection into C57BL/6 × DBA/2 F1 hybrid blastocysts. Doxycycline (Dox) treatment was carried out as previously described (Ohnishi et al., 2014) . All mice used in this study were maintained on a standard LD12:12 schedule with ad libitum food access.
| Induction of reprogrammed cells in vitro
Tet-OSKM/mPer2-luc ESCs were differentiated as previously described . Briefly, after the ESCs were trypsinized and feeder cells were removed, embryoid bodies (EBs) were generated by harvesting 2,000 cells and seeding them onto low-attachment 96-well plates (Lipidure Coat, NOF) in a differentiating medium without leukemia inhibitory factor (LIF) supplementation (EFM), which is comprised of high-glucose DMEM (NacalaiTesque) containing 10% fetal bovine serum (FBS, Hyclone), 1 mM sodium pyruvate, 0.1 mM MEM nonessential amino acids (NacalaiTesque), GlutaMax ™ -I (Invitrogen), 100 μM StemSure ® 2-mercaptoethanol solution (Wako), and 100 units/ml penicillin-streptomycin (NacalaiTesque). Two days later, EBs were plated onto gelatin-coated tissue culture 24-well plates and grown for several additional weeks. EFM was changed every 1-2 days. After in vitro 21-day differentiation of Tet-OSKM/mPer2-luc ESCs, the medium was replaced by Glasgow minimum essential medium (G-MEM, Wako) supplemented with a 15% FBS, 0.1 mM MEM nonessential amino acids, 100 μM StemSure ® 2-mercaptoethanol solution, penicillin and streptomycin (ESM) containing 1 μg/ ml Dox. Four days after the Dox addition, the cells were reseeded on feeder cells and the medium was replaced by ESM supplemented with LIF and Dox. The medium was changed every day. ESC-like colonies were picked up and then cultured on the feeder cells without Dox.
| Real-time bioluminescence analysis
Normal kidney and kidney tumor tissue samples of mice were submerged in cold Hank's balanced salt solution (NacalaiTesque) for thin (250 μm) sectioning using a vibratome. The kidney sections were put on porous Millicell membrane inserts (Millipore) and observed using macroscopic imaging analyzer (Olympus) (Hara et al., 2017) . The medium was DMEM containing 0.2 mM luciferin (Promega), 2% B-27 (Gibco), 1% Glutamax (Gibco), penicillin and streptomycin (NacalaiTesque), and 10 mM HEPES without phenol red. Time-lapse images were collected at 60-min intervals with 0.5-to 3-min exposures. Further analysis was carried out using AquaCosmos software (Hamamatsu Photonics). For iPS cells, real-time bioluminescence analysis was carried out as previously described . The in vitro differentiated cells or iPS cells were seeded in 24-well black plates or 35-mm dishes. The medium was replaced with phenol red-free EFM containing 0.2 mM luciferin and 15 mM HEPES or ESM containing LIF, 0.2 mM luciferin, and 10 mM HEPES. Cells were treated with 100 nM dexamethasone (Sigma) for synchronization. The plates and dishes were set on a turntable in an in-house fabricated real-time monitoring system developed by Dr Takao Kondo (Nagoya University; Kiyohara et al., 2006) . The bioluminescence from each well or dish was counted for 1 min at 20-min intervals.
| Human sample
Formalin-fixed and paraffin-embedded tissue was retrieved with informed consent from archive sources at Kyoto Prefectural University of Medicine. The histologic diagnosis of Wilms tumor and MRT was confirmed on hematoxylinand eosin-stained sections.
| Histological analysis and immunostaining
Normal kidney and kidney tumor tissue samples of mice extracted at ZT4 and ZT8 were fixed in 10% buffered formalin overnight and embedded in paraffin (Tokyo Central Pathology Laboratory, Japan). The paraffin-embedded human Wilms tumor and MRT samples were stored and controlled by the department of pediatric surgery, Kyoto Prefectural University of Medicine. The tissues sectioned into 5-μm-thick slices with a rotary microtome (Leica RM2265) or a sliding microtome (LS-113; Yamato-Kohki, Japan). Slices were stained with hematoxylin and eosin (Tokyo Central Pathology Laboratory, Japan), and the serial sections were used for the immunostaining using CLSP4 anti-CLOCK mouse monoclonal antibody (1:500 or 1:2,000 dilution, a kind gift from Drs Hikari Yoshitane and Yoshitaka
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Fukada, University of Tokyo, Tokyo) (Yoshitane et al., 2009) for three nights at 4°C after the inactivation of endogenous peroxidase. Then, they were incubated with biotinylated antimouse IgG and with an avidin-biotin peroxidase complex (Vectastain Elite ABC kit; Vector Laboratories). For MRT, anti-CLOCK primary antibody was visualized by Histofine Simple Stain MAX-PO kit (Nichirei, Tokyo, Japan) according to the manufacturer's protocol. And the peroxidase was visualized using ImmPACT DAB peroxidase substrate (Vector Laboratories). Subsequently, the slides were counterstained with hematoxylin. The images were acquired using a Nikon Eclipse E800M (Nikon) or a BZ-X710 microscope (KEYENCE).
For iPS cells, the cells were fixed with PBS containing 3.7% paraformaldehyde for 10 min at room temperature and blocked with 5% skim milk and 0.1% Triton X-100 for 45 min at room temperature and then treated with anti-NANOG 1:200 (ReproCELL, Japan) overnight at 4°C, carried out as previously described (Inada et al., 2014) . After washing with PBS, the cells were incubated with the secondary antibodies Cy3-labeled anti-rabbit IgG (1:1,000, Jackson). The nuclei were stained with Hoechst 33342 (NacalaiTesque). The cells were observed using an LSM510 confocal laser scanning microscope (Zeiss).
| Whole transcriptome sequencing (RNA-seq)
Tissue samples were homogenized in Invitrogen TRIzol reagent. RNA was extracted using QIAGEN RNeasy columns as per manufacturer's protocol. Total RNA (0.25 μg) was depleted of ribosomal RNAs using Ribo-Zero Gold (Illumina). Sequencing libraries were constructed using a TruSeq Stranded Total RNA LT Sample Prep Kit according to the manufacturer's instruction (Illumina). Sequencing of libraries was carried out on an Illumina NEXTseq500 instrument with 86-bp single-end reads (Illumina) by the Department of Life Science Frontiers, Center for iPS Cell Research and Application (CiRA), Kyoto University. Trimmomatic was used to remove adaptor sequences (Bolger, Lohse, & Usadel, 2014) . Sequence reads were mapped to mouse genome mm10 with STAR (2.5.0c). To obtain reliable alignments, the reads with mapping quality less than 10 were removed with SAM tools (Li et al., 2009) . The UCSC known canonical genes (32,958 in total) were quantified using Homer. The Gene Expression Omnibus accession number for the data is GSE107261.
| Data analysis
For FFT (Fast Fourier Transform) analysis, the raw data recorded for 4 days was detrended by subtracting a 24-hr moving average and FFT was carried out using Microsoft Excel 2010, and then, the relative spectral power density (relative power) at the peak within the range of 21-26 hr was obtained.
| Statistical analysis
Because the variances of data were not equal, statistical significance was determined using a nonparametric KruskalWallis test followed by Dunn's multiple comparison test using R or GraphPad Prism 6.0 software, and significance was defined as p <.01.
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